Evidence map›Paper›PMID 35880017›Full record

ArticleCell reports methods2022

Endogenous spacing enables co-processing of microRNAs and efficient combinatorial RNAi.

Alexandra M Amen, Ryan M Loughran, Chun-Hao Huang, Rachel J Lew, Archna Ravi, Yuanzhe Guan, Emma M Schatoff, Lukas E Dow, Brooke M Emerling, Christof Fellmann

Open access · goldAbstract read
In one paragraph

Article in Cell reports methods, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Alexandra M AmenGladstone Institute of Data Science and Biotechnology, Gladstone Institutes, San Francisco, CA, USA.
Ryan M LoughranCell and Molecular Biology of Cancer Program, Sanford Burnham Prebys, La Jolla, CA, USA.
Chun-Hao HuangMemorial Sloan Kettering Cancer Center, New York, NY, USA.
Rachel J LewGladstone Institute of Data Science and Biotechnology, Gladstone Institutes, San Francisco, CA, USA.
Archna RaviCell and Molecular Biology of Cancer Program, Sanford Burnham Prebys, La Jolla, CA, USA.
Yuanzhe GuanMirimus Inc., Brooklyn, NY, USA.
Emma M SchatoffWeill Cornell Graduate School of Medical Sciences, Weill Cornell Medicine, New York, NY, USA.
Lukas E DowSandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.
Brooke M EmerlingCell and Molecular Biology of Cancer Program, Sanford Burnham Prebys, La Jolla, CA, USA.
Christof FellmannGladstone Institute of Data Science and Biotechnology, Gladstone Institutes, San Francisco, CA, USA.
Gladstone Institutes · USSanford Burnham Prebys Medical Discovery Institute · USCornell University · USMemorial Sloan Kettering Cancer Center · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Tumor Microenvironment and Cancer ImmunologyP30CA030199 · NCI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI Michael Jackson · 1985 to 2026
$107.2M
Non-Canonical Phosphatidylinositol Kinases in Triple Negative Breast CancerR01CA237536 · NCI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI EMERLING, BROOKE M · 2020 to 2024
$2.2M
Cancer Targets and Drug DiscoveryT32CA211036 · NCI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI COSFORD, NICHOLAS DAVID · 2018 to 2022
$1.2M
Mechanism and Therapeutic Application of RNA-Guided Immune SystemsR00GM118909 · NIGMS · J. DAVID GLADSTONE INSTITUTES · PI FELLMANN, CHRISTOF · 2018 to 2020
$747k
Mapping cellular communication at single-cell resolution through novel CRISPR systemsR35GM143124 · NIGMS · J. DAVID GLADSTONE INSTITUTES · PI FELLMANN, CHRISTOF · 2021 to 2021
$473k
Mechanism and therapeutic application of RNA-guided immune systemsK99GM118909 · NIGMS · UNIVERSITY OF CALIFORNIA BERKELEY · PI FELLMANN, CHRISTOF · 2016 to 2017
$180k
NCI NIH HHS P30 CA008748NCI NIH HHS P30 CA030199NCI NIH HHS R01 CA237536NCI NIH HHS T32 CA211036NIGMS NIH HHS K99 GM118909NIGMS NIH HHS R00 GM118909NIGMS NIH HHS R35 GM143124
6 · The paper itself

Abstract

We present Multi-miR, a microRNA-embedded shRNA system modeled after endogenous microRNA clusters that enables simultaneous expression of up to three or four short hairpin RNAs (shRNAs) from a single promoter without loss of activity, enabling robust combinatorial RNA interference (RNAi). We further developed complementary all-in-one vectors that are over one log-scale more sensitive to doxycycline-mediated activation

Indexed as

MicroRNAsAnimalsGenetic VectorsMicePromoter Regions, GeneticRNA InterferenceRNA, Small InterferingMicroRNAsRNA, Small Interferingcancer modelingcombinatorial target inhibitiongene regulationmicroRNARNAiRNA interferencetarget discoverytarget validationviral vectors

Identifiers

PMID35880017
PMCPMC9308131
OpenAlexW4283276824

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.